Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Tax Provisions (2011 - 2026)

Updated

Regeneron Pharmaceuticals' Tax Provisions was $230.9 million in Q2 2026, up 81.7% from $127.1 million a year earlier and up 122.0% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Tax Provisions (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Regeneron Pharmaceuticals' Tax Provisions was $837.3 million through Jun 30, 2026, up 101.2% year-over-year; for FY2025, it was $725.8 million, up 97.6% from FY2024.

  • Tax Provisions shows a five-year compound annual growth rate of 19.6% (FY2020 to FY2025).
  • In earlier years, Tax Provisions was $367.3 million in FY2024 (+49.5%), $245.7 million in FY2023 (-52.8%), $520.4 million in FY2022 (-58.4%) and $1.25 billion in FY2021 (+320.8%).
  • Quarterly Tax Provisions has moved between -$21.3 million (Q1 2024) and $303.3 million (Q3 2025) over five years.
  • Compared with a year earlier, Tax Provisions has increased for four straight quarters, with growth averaging 99.1% over the last six quarters.
  • The best year-over-year quarter for Tax Provisions over five years was Q4 2025 (growth of 392.8%); the worst was Q2 2022 (a decline of 83.0%).
  • Per Business Quant data, REGN's Tax Provisions in the three quarters before Q2 2026 was $104 million (Q1 2026), $199.1 million (Q4 2025) and $303.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 2.15 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 1.21 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 662.00 Mn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 654.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 291.00 Mn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 393.00 Mn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 242.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -407.00 Mn
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 230.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 230.90 Mn
Mar 31, 2026 104.00 Mn
Dec 31, 2025 199.10 Mn
Sep 30, 2025 303.30 Mn
Jun 30, 2025 127.10 Mn
Mar 31, 2025 96.30 Mn
Dec 31, 2024 40.40 Mn
Sep 30, 2024 152.40 Mn
Jun 30, 2024 195.80 Mn
Mar 31, 2024 -21.30 Mn
Dec 31, 2023 -12.00 Mn
Sep 30, 2023 103.00 Mn
Jun 30, 2023 114.50 Mn
Mar 31, 2023 40.20 Mn
Dec 31, 2022 127.60 Mn
Sep 30, 2022 194.10 Mn
Jun 30, 2022 111.10 Mn
Mar 31, 2022 87.60 Mn
Dec 31, 2021 274.40 Mn
Sep 30, 2021 184.40 Mn
API Access

Regeneron Pharmaceuticals Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=REGN&period=max&api_key=YOUR_API_KEY